Credicorp Ltd. BAP 深 滬
等待開盤 10-27 09:30:00 美东时间
256.80
-1.130
-0.44%
華盛通- 最 高260.15
- 今 開258.42
- 成交量 13.11万股
- 最 低 256.80
- 昨 收 257.93
- 總市值 203.81亿
- 52周最高 280.88
- 市盈率 靜 13.95
- 換手率 0.17%
- 52周最低 154.6701
- 委 比 4.76%
- 總股本 7936.63万
- 歷史最高 280.88
- 量 比 0.51
- 振 幅 1.30%
- 歷史最低 8.7834
- 每 手 1
- 風險率 34.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多2025年10月中国宝宝辅食品牌评测：安全营养双维度解析
（来源：衡水日报） 转自：衡水日报 当家长第一次走进辅食区，货架上密密麻麻的包装让人瞬间陷入选择焦虑：宝宝第一口辅食到底该选什么？能不能兼顾低敏、高铁、易吞咽...
10-23 15:08
Bapcor’s Strategic Turnaround: Simplifying for Growth
The latest update is out from Bapcor Ltd ( ($AU:BAP) ). Bapcor Limited held its...
10-23 07:08
Bapcor Ltd Announces Strategic Initiatives Amid Challenging Market Conditions
Bapcor Ltd ( ($AU:BAP) ) has shared an announcement. Bapcor Ltd has announced a...
10-20 08:48
Credicorp Ltd.: Credicorp Held Investor Day Marking 30 Years on NYSE and Presented Vision for a Future-Ready Financial Ecosystem
<p><p><em>Lima, Peru, October 10, 2025</em> – Credicorp hosted its 2025 Investor Day in New York, marking the 30th anniversary of its NYSE listing. The event highlighted the company’s strategic pillars: purpose, innovation, culture & talent, and governance. Over three decades, Credicorp delivered a 14.1% annual TSR, decoupling from Peru’s macroeconomic cycle. The company aims to achieve a sustainable ROE of 19.5% and a C/I ratio near 42% in the n...
10-10 20:15
美股盘后 | Hims & Hers Health涨2.19%，Palantir涨1.68%
Hims & Hers Health涨2.19%；Palantir涨1.68%；帝亚吉欧涨1.56%
10-04 06:11
金秋蟹季拉开帷幕：南北产区接力上市，标准化趋势显现
伴随秋意渐浓，全国各地大闸蟹陆续“爬”上消费者餐桌。 大闸蟹，学名中华绒螯蟹，因生长环境和捕捞方式不同，在部分产区也被概括为河蟹、簖蟹等。不同产区的大闸蟹错峰登...
09-30 20:36
"2025 永利臻典梦幻超跑展"隆重揭幕 定义奢华展览新高度
与澳门格兰披治大赛车并驾齐驱打造"旅游＋体育"多元体验 澳门2025年9月30日 /美通社/ -- 在澳门特别行政区政府旅游局及澳门特别行政区政府体育局的大力支...
09-30 14:17
Top 3 Financial Stocks That Are Ticking Portfolio Bombs
As of Sept. 17, 2025, three stocks in the financial sector could be flashing a ...
09-17 19:22
美股大行评级 | Arete Research上调百度"买入"评级，目标价143美元；瑞银上调蔚来"买入"评级，目标价升至8.5美元
今日重点评级关注：HC Wainwright & Co.：维持Orion Energy Sys"买入"评级，目标价从2美元升至20美元；高盛：维持Amylyx Pharmaceuticals"买入"评级，目标价从10美元升至20美元
09-17 10:15
UBS Maintains Buy on Credicorp, Raises Price Target to $318
UBS analyst Thiago Batista maintains Credicorp (NYSE:BAP) with a Buy and raises the price target from $257 to $318.
09-16 20:40
